2 research outputs found

    Implementation of a coded-reference ultra-wideband system

    Get PDF
    Ankara : The Department of Electrical and Electronics Engineering and the Institute of Engineering and Sciences of Bilkent University, 2011.Thesis (Master's) -- Bilkent University, 2011.Includes bibliographical references leaves 60-64.Coded-reference ultra-wideband (CR UWB) systems provide orthogonalization of the reference and data signals in the code domain to facilitate communications without the need for complex channel estimation and have significant advantages over the previous techniques in terms of performance and/or implementation complexity. This thesis presents a UWB testbed as a general experimental platform to explore pulse-based UWB communications and discusses design and implementation issues. A testbed is built as a flexible solution for hardware implementation of a CR UWB system.Gürlevik, OsmanM.S

    Changing Disease Course of Crimean-Congo Hemorrhagic Fever in Children, Turkey

    No full text
    Crimean-Congo hemorrhagic fever (CCHF), endemic in certain regions of the world, is listed as a priority disease with pandemic potential. Since CCHF was first identified in Turkey, children have been known to experience milder disease than adults. However, during the COVID-19 pandemic, we observed an unusually severe disease course, including hemophagocytic lymphohistiocytosis (HLH). We examined cytokine/chemokine profiles of 9/12 case-patients compared with healthy controls at 3 time intervals. Interferon pathway–related cytokines/chemokines, including interleukin (IL) 18, macrophage inflammatory protein 3α, and IL-33, were elevated, but tumor necrosis factor-α, IL-6, CXCL8 (formerly IL-8), and cytokines acting through C-C chemokine receptor 2 and CCR5 were lower among case-patients than controls. Interferon pathway activation and cytokines/chemokines acting through CCR2 and CCR5 improved health results among children with severe CCHF. Children can experience severe CCHF, including HLH, and HLH secondary to CCHF can be successfully treated with intravenous immunoglobulin and steroid therapy
    corecore